gadophrin-2

12/01/2002 - "However, the trend and degree of enhancement by gadophrin-2 could be helpful in discrimination between viable tumor and tumor necrosis."
02/01/1999 - "Mechanism of gadophrin-2 accumulation in tumor necrosis."
02/01/2002 - "T1- and T2-weighted MRI was performed 6 hours after administration of the necrosis avid contrast agent Gadophrin-2 at 0.05 mmol/kg. Gradient-echo cine MRI series were performed at baseline and at 6 hours. "
02/01/2001 - "On delayed phase (>60 minutes), a necrosis-specific contrast enhancement (contrast ratio 1.6) developed with gadophrin-2 but not with MP-2269. "
02/01/2001 - "The mechanisms of action leading to specific localization of necrosis-avid contrast agents (NACAs) such as gadophrin-2 are not well defined. "

02/01/1999 - "Accumulation of gadophrin-2 was low (<0.7% injected dose/g tissue at 24 hours after injection) in viable tumor but higher in necrotic tumor regions and was readily detectable by MRI. "
02/01/1999 - "The molecular mechanism by which gadophrin-2 targets necrotic tumor tissue was investigated. "
12/01/2002 - "However, the trend and degree of enhancement by gadophrin-2 could be helpful in discrimination between viable tumor and tumor necrosis."
12/01/2002 - "In tumors and abscesses, peripheral-rim enhancement appeared on MRI at 1, 3, 5, 10, 30 minutes after injection of gadophrin-2. "
02/01/1999 - "Mechanism of gadophrin-2 accumulation in tumor necrosis."

01/01/2001 - "The aim of this study was to compare intracoronary (i.c.) administration of Gadophrin-2, a necrosis-avid contrast agent (NACA), and nonspecific agent Gd-DTPA for determination of myocardial viability (MV) in acute myocardial infarction (AMI) with MRI. "

01/01/2001 - "The infarct size defined with Gadophrin-2 was almost identical to that with TTC staining throughout the postcontrast period. "
02/09/1999 - "One day (group A), 2 days (group B), or 6 days (group C) after infarction, gadophrin-2 was injected intravenously (50 micromol. "

12/01/2002 - "Dynamic enhancement features of gadophrin-2 on magnetic resonance imaging: an experimental model of VX2 carcinoma and bacterial abscess in rabbit thigh."